Stocks TelegraphStocks Telegraph
Stock Ideas

AIDX Financial Statements and Analysis

NASDAQ : AIDX

20/20 Biolabs Common Stock

$0.98
-0.225-18.67%
At Close 4:00 PM
$1.02
+0.0400+4.08%
After-Market 08:30 PM

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2026
reported currencyUSD
calendar year2026
periodQ1
revenue353.375K
cost of revenue290.491K
gross profit62.884K
gross profit ratio0.178
research and development expenses153.482K
general and administrative expenses0
selling and marketing expenses0
selling general and administrative expenses1.353M
other expenses0
operating expenses1.506M
cost and expenses1.797M
interest income6.653K
interest expense-267.008K
depreciation and amortization0
ebitda-1.443M
ebitda ratio-4.084
operating income-1.443M
operating income ratio-4.084
total other income expenses net-677.288K
income before tax-2.121M
income before tax ratio-6.001
income tax expense0
net income-2.121M
net income ratio-6.001
eps-0.28
eps diluted-0.28
weighted average shs out7.657M
weighted average shs out dil7.657M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2026
reported currencyUSD
calendar year2026
periodQ1
cash and cash equivalents4.219M
short term investments0
cash and short term investments4.219M
net receivables201.481K
inventory104.523K
other current assets175.174K
total current assets4.70M
property plant equipment net607.694K
goodwill0
intangible assets206.801K
goodwill and intangible assets206.801K
long term investments0
tax assets0
other non current assets288.575K
total non current assets1.103M
other assets0
total assets5.803M
account payables980.486K
short term debt189.649K
tax payables0
deferred revenue450.667K
other current liabilities959.243K
total current liabilities2.58M
long term debt429.122K
deferred revenue non current0
deferred tax liabilities non current0
other non current liabilities0
total non current liabilities429.122K
other liabilities0
capital lease obligations618.771K
total liabilities466.177K
preferred stock54.192K
common stock104.43K
retained earnings-35.422M
accumulated other comprehensive income loss0
other total stockholders equity37.871M
total stockholders equity2.553M
total equity2.553M
total liabilities and stockholders equity3.019M
minority interest0
total investments0
total debt618.771K
net debt-3.60M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2026
reported currencyUSD
calendar year2026
periodQ1
deferred income tax0
stock based compensation128.44K
change in working capital0
accounts receivables-1.527K
inventory11.694K
accounts payables111.941K
other working capital0
other non cash items694.058K
net cash provided by operating activities-1.289M
investments in property plant and equipment0
acquisitions net0
purchases of investments0
sales maturities of investments0
other investing activites-5.354K
net cash used for investing activites-5.354K
debt repayment0
common stock issued5.00M
common stock repurchased0
dividends paid-54.192K
other financing activites4.542M
net cash used provided by financing activities4.487M
effect of forex changes on cash0
net change in cash3.193M
cash at end of period4.219M
cash at beginning of period1.026M
operating cashflow-1.289M
capital expenditure0
free cash flow-1.289M
Graph

Frequently Asked Questions

How did 20/20 Biolabs, Inc. Common Stock do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, AIDX generated $353.38K in revenue last quarter, while its costs came in at $290.49K.
Last quarter, how much Gross Profit did 20/20 Biolabs, Inc. Common Stock report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. 20/20 Biolabs, Inc. Common Stock reported a $62.88K Gross Profit for the quarter ended Mar 31, 2026.
Have AIDX's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. AIDX incurred $1.51M worth of Operating Expenses, while it generated -$1.44M worth of Operating Income.
How much Net Income has AIDX posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from 20/20 Biolabs, Inc. Common Stock, the company generated -$2.12M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did 20/20 Biolabs, Inc. Common Stock have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to 20/20 Biolabs, Inc. Common Stock as of the end of the last quarter was $4.22M.
What are AIDX's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, AIDX had Total Net Receivables of $201.48K.
In terms of Total Assets and Current Assets, where did 20/20 Biolabs, Inc. Common Stock stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of AIDX were $4.70M, while the Total Assets stand at $5.80M.
As of the last quarter, how much Total Debt did 20/20 Biolabs, Inc. Common Stock have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of AIDX's debt was $618.77K at the end of the last quarter.
What were AIDX's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, AIDX reported total liabilities of $466.18K.
How much did AIDX's Working Capital change over the last quarter?
Working Capital Change for AIDX was $0.00 over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
AIDX generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. AIDX generated -$1.29M of Cash from Operating Activities during its recently reported quarter.
What was AIDX's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. AIDX reported a $3.19M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph